Literature DB >> 2969166

Therapeutic activity of teicoplanin on experimental listeriosis compared with that of vancomycin and ampicillin.

R Berner1, H Hof.   

Abstract

Several strains of Listeria monocytogenes and other Listeria spp. are without exception susceptible to teicoplanin (MIC 0.25 mg/l). Vancomycin as well as ampicillin are likewise active. A bactericidal effect of teicoplanin was only achieved at rather high concentrations and after incubation of several hours. There is no synergistic effect between teicoplanin and gentamicin. The therapeutic activity of teicoplanin as well as vancomycin in mice infected with L. monocytogenes is low. The efficacy of ampicillin could not be achieved. Treatment of chronically infected athymic, nude mice with teicoplanin is ineffective. Consequently, teicoplanin is not able to replace ampicillin in the therapy of listeriosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969166     DOI: 10.1016/s0176-6724(88)80114-7

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0176-6724


  4 in total

Review 1.  Management of listeriosis.

Authors:  H Hof; T Nichterlein; M Kretschmar
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 2.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

Review 3.  Antimicrobial chemotherapy of human infection due to Listeria monocytogenes.

Authors:  E M Jones; A P MacGowan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

Review 4.  Therapeutic activities of antibiotics in listeriosis.

Authors:  H Hof
Journal:  Infection       Date:  1991       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.